Article

Evaluating cell free DNA quantification and integrity in breast cancer using fluorometric, electrophoretic and PCR based platforms

2026-02-25

Abstract excerpt

<title>Abstract</title> <p>Background Cell-free DNA (cfDNA) has emerged as a promising biomarker for cancer detection and monitoring. However, different quantification and integrity assessment methods may yield variable results. This study aimed to compare cfDNA concentration and integrity between breast cancer (BC) patients and healthy controls using three complementary analytical techniques and to evaluate the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a247a004-0e37-53be-b13a-b841facb913f
DOI: 10.21203/rs.3.rs-8794932/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating cell free DNA quantification and integrity in breast cancer using fluorometric, electrophoretic and PCR based platformsDOI 10.21203/rs.3.rs-8794932/v1Read

Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individualsSemantic proximity Read

Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Semantic proximity Read

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencingSemantic proximity Read

Use of cell free DNA in breast oncology.Semantic proximity Read

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing.Semantic proximity Read

Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.Semantic proximity Read

Altered cfDNA Fragmentation Profile in Hypomethylated Regions as Diagnostic Marker in Breast CancerSemantic proximity Read

Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancerSemantic proximity Read

Preanalytical variables that affect the outcome of cell-free DNA measurementsSemantic proximity Read

Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancersSemantic proximity Read

Differentially methylated regions (DMRs)-dependent cfDNA fragmentation profile for diagnosis of breast cancerSemantic proximity Read